Potential conflict of interest: Dr. Berger has received grants from Bayer Pharmaceutical and Serono-EMD. He serves as a consultant to Asphelia, Astellas, Bayer, Genentech, Glaxo-SmithKline, Millenium, Merck-Serono, and Teva. He is on the speakers board of Bayer, Pfizer, Serono, and Teva.
Opportunistic infections and other risks with newer multiple sclerosis therapies†
Article first published online: 19 MAR 2009
Copyright © 2009 American Neurological Association
Annals of Neurology
Volume 65, Issue 4, pages 367–377, April 2009
How to Cite
Berger, J. R. and Houff, S. (2009), Opportunistic infections and other risks with newer multiple sclerosis therapies. Ann Neurol., 65: 367–377. doi: 10.1002/ana.21630
- Issue published online: 27 APR 2009
- Article first published online: 19 MAR 2009
- Accepted manuscript online: 19 MAR 2009 12:00AM EST
- Manuscript Accepted: 12 DEC 2008
- Manuscript Revised: 10 DEC 2008
- Manuscript Received: 13 NOV 2008
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.